Checkpoint Capital L.P. AVDL Holdings History
Checkpoint Capital L.P.'s Avadel Pharmaceuticals PLC Holding Summary
As of 2025-03-31, Checkpoint Capital L.P. held - shares of Avadel Pharmaceuticals PLC(AVDL), totaling N/A. This investment constitutes 0% of their stock portfolio, and Checkpoint Capital L.P. now holds 0% of the outstanding Avadel Pharmaceuticals PLC(AVDL) stock.
The initial trade took place in 2023Q4. And since then Checkpoint Capital L.P. has made 2 purchases of AVDL, at an average price of $14.53, for a total of 1.14 Mil shares. In addition, there have been 3 sales at an average price of $8.91 for 1.14 Mil shares. Based on historical transaction data and AVDL's current price of $8.97, Checkpoint Capital L.P.'s estimated gain on his AVDL holdings is $-6.40 Mil, reflecting a -38.67% gain to date.
Checkpoint Capital L.P. AVDL ($8.97) Holding Chart
Checkpoint Capital L.P. AVDL ($8.97) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
